Literature DB >> 9473480

Structure, chromosomal location, and expression profile of EXTR1 and EXTR2, new members of the multiple exostoses gene family.

T Saito1, N Seki, M Yamauchi, S Tsuji, A Hayashi, S Kozuma, T Hori.   

Abstract

Hereditary multiple exostoses (EXT) is an autosomal dominant disorder that is characterized by the appearance of multiple outgrowths of the long bones (exostoses) at their epiphyses. Genetical heterogeneities have segregated at least on chromosome 8, 11, and 19 and been designated EXT1, EXT2, and EXT3, respectively. Recently, the responsible genes for EXT1 and EXT2 have been isolated and appeared to define a structurally related gene family. In the present study, we have identified novel genes which share significant sequence homologies with the EXT genes. The predicted protein products of the novel EXT-related genes, EXTR and EXTR2 (for EXT-related genes 1 and 2), consist of 919 and 330 amino acid residues, respectively. These genes were transcribed ubiquitously in various tissues. Based on PCR-assisted analyses of both a human/rodent mono-chromosomal hybrid cell panel and a radiation hybrid mapping panel, EXTR1 was localized to the chromosome 8p21 region, where loss of heterozygosity has been frequently observed in various tumors, and EXTR2 was assigned to the chromosome 1p21 region, where osteopetrosis, a dominant hereditary disease of bone, has been mapped by genetic linkage analysis, implying that the protein products of these two EXT-related genes, as well as of the EXT genes, have potential tumor suppressor activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473480     DOI: 10.1006/bbrc.1997.8062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Increased urine heparan and chondroitin sulphate excretion in patients with osteopetrosis.

Authors:  R D Steiner; M P Whyte; E Chang; J Hanks; C Mattes; H Senephansiri; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

Review 2.  The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.

Authors:  G Duncan; C McCormick; F Tufaro
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

3.  Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis.

Authors:  T T Glant; V A Adarichev; F Boldizsar; T Besenyei; A Laszlo; K Mikecz; T A Rauch
Journal:  Genes Immun       Date:  2012-03-08       Impact factor: 2.676

4.  Heparan sulfate containing unsubstituted glucosamine residues: biosynthesis and heparanase-inhibitory activity.

Authors:  Satomi Nadanaka; Eko Purunomo; Naoko Takeda; Jun-ichi Tamura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

Review 5.  Reg3 Proteins as Gut Hormones?

Authors:  Jae Hoon Shin; Randy J Seeley
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

6.  Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.

Authors:  P K Cheung; C McCormick; B E Crawford; J D Esko; F Tufaro; G Duncan
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

7.  Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.

Authors:  B T Kim; H Kitagawa; J Tamura ; T Saito; M Kusche-Gullberg; U Lindahl; K Sugahara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 8.  Of hedgehogs and hereditary bone tumors: re-examination of the pathogenesis of osteochondromas.

Authors:  Kevin B Jones; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2003

9.  EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner.

Authors:  Satomi Nadanaka; Shaobo Zhou; Shoji Kagiyama; Naoko Shoji; Kazuyuki Sugahara; Kazushi Sugihara; Masahide Asano; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.